P2X7 inhibition may have affected glioma tumor cells spreading as evidenced by a decrease of matrix metalloproteinase-2 activity and decrease (β-catenin) or total reduction (N-cadherin and vimentin) of EMT-related proteins. The gene discussed is CDH2; the disease is central nervous system cancer.